Want to see IN:ASTERDM full AI Analyst Report?
ASTERDM Stock Chart & Stats
₹615.20
-₹6.20(-1.19%)
At close: 4:00 PM EST
₹615.20
-₹6.20(-1.19%)
Day’s Range― - ―
52-Week Range₹519.80 - ₹847.95
Previous CloseN/A
Volume549.11K
Average Volume (3M)57.99K
Market Cap
₹418.82B
Enterprise Value₹404.89B
Total Cash (Recent Filing)₹13.27B
Total Debt (Recent Filing)₹22.20B
Price to Earnings (P/E)107.4
Beta0.46
Next Earnings
Aug 06, 2026EPS Estimate
2.2Next Dividend Ex-DateN/A
Dividend Yield0.84%
Share Statistics
EPS (TTM)7.53
Shares Outstanding518,121,030
10 Day Avg. Volume86,592
30 Day Avg. Volume57,995
Financial Highlights & Ratios
PEG Ratio-0.96
Price to Book (P/B)7.55
Price to Sales (P/S)7.44
P/FCF Ratio171.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)12.14
Revenue Forecast (FY)₹57.21B
Bulls Say, Bears Say
Bulls Say
Improved Operating MarginsSustained double-digit EBITDA and mid-teens EBIT margins indicate the company can capture value from clinical services and manage costs across its network. Durable margins support internal investment, pricing power and resilience to modest volume swings over the next 2–6 months.
Lower LeverageMeaningful deleveraging materially reduces financial risk and interest burden, improving liquidity and strategic flexibility. A ~0.5x debt/equity ratio lowers refinancing pressure and supports capital allocation for expansion or capex over the medium term.
Return To Positive Free Cash FlowA rebound to positive FCF and stronger operating cash flow signals improved cash conversion capacity. Even if FCF share is modest, consistent positive FCF provides funding to pay down debt, reinvest in facilities, and sustain operations without immediate external financing.
Bears Say
Earnings VolatilityHigh variability in reported earnings, including an anomalous FY2025 spike, undermines predictability of future profits and complicates budgeting, credit assessment and valuation. Persistent volatility weakens confidence in the sustainability of margins and cash returns.
Inconsistent Cash ConversionLow FCF relative to net income and erratic operating cash coverage suggest working-capital swings or timing differences. This raises the risk that earnings improvements may not translate into available cash for debt reduction, capex or shareholder returns consistently.
Historical High Debt And Uneven ReturnsA history of elevated leverage combined with volatile ROE indicates cyclical exposure and past reliance on debt to boost returns. If earnings revert, leverage could amplify downside and limit the company's ability to invest or respond to industry shocks.
Aster DM Healthcare Ltd. News
ASTERDM FAQ
What was Aster DM Healthcare Ltd.’s price range in the past 12 months?
Aster DM Healthcare Ltd. lowest stock price was ₹519.80 and its highest was ₹847.95 in the past 12 months.
What is Aster DM Healthcare Ltd.’s market cap?
Aster DM Healthcare Ltd.’s market cap is ₹418.82B.
When is Aster DM Healthcare Ltd.’s upcoming earnings report date?
Aster DM Healthcare Ltd.’s upcoming earnings report date is Aug 06, 2026 which is in 24 days.
How were Aster DM Healthcare Ltd.’s earnings last quarter?
Aster DM Healthcare Ltd. released its earnings results on Apr 30, 2026. The company reported ₹2.7 earnings per share for the quarter, beating the consensus estimate of ₹1.6 by ₹1.1.
Is Aster DM Healthcare Ltd. overvalued?
According to Wall Street analysts Aster DM Healthcare Ltd.’s price is currently Overvalued.
Does Aster DM Healthcare Ltd. pay dividends?
Aster DM Healthcare Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of 0.84%. See more information on Aster DM Healthcare Ltd. dividends here
What is Aster DM Healthcare Ltd.’s EPS estimate?
Aster DM Healthcare Ltd.’s EPS estimate is 2.2.
How many shares outstanding does Aster DM Healthcare Ltd. have?
Aster DM Healthcare Ltd. has 518,121,030 shares outstanding.
What happened to Aster DM Healthcare Ltd.’s price movement after its last earnings report?
Aster DM Healthcare Ltd. reported an EPS of ₹2.7 in its last earnings report, beating expectations of ₹1.6. Following the earnings report the stock price went up 0.279%.
Which hedge fund is a major shareholder of Aster DM Healthcare Ltd.?
Currently, no hedge funds are holding shares in IN:ASTERDM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aster DM Healthcare Ltd.
Aster DM Healthcare Ltd. operates as an international healthcare provider with a significant presence in India and other global regions. The company's operations are segmented across hospitals, clinics, retail pharmacies, and other diversified services. It delivers a comprehensive range of medical care, from fundamental primary care to highly specialized quaternary services, supported by a vast infrastructure. This network includes 29 hospitals, 120 clinics, 371 retail pharmacies, 114 laboratories, and numerous patient experience centers, all operating under well-known brands such as Aster, Medcare, and Access. Beyond direct patient care, the company also provides healthcare retailing, diagnostic testing, digital health solutions, and medical education. Established in 1987, Aster DM Healthcare maintains its corporate headquarters in Dubai, United Arab Emirates.
Technical Analysis
Ajanta Pharma Limited
―
Gland Pharma Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Global Health Limited
―
Narayana Hrudayalaya Ltd.
―